These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29635632)

  • 81. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 82. What is your gut feeling about opioid rotation?
    Didwaniya N; Reddy A; Gottumukkala RS; Bruera E
    J Clin Oncol; 2015 Jan; 33(3):e11-2. PubMed ID: 24590650
    [No Abstract]   [Full Text] [Related]  

  • 83. [Hydromorphone in Cancer Patients-A Retrospective Study].
    Sato N; Satomi E; Yoshida T; Shimizu M; Kiuchi D; Ishiki H
    Gan To Kagaku Ryoho; 2020 Dec; 47(12):1687-1690. PubMed ID: 33342984
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pain Management Using Perioperative Administration of Parecoxib for Total Hip Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Xiao K; Yu L; Xiao W; Peng H; Bian Y; Wu Z; Weng X
    Pain Physician; 2019 Nov; 22(6):575-582. PubMed ID: 31775404
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors.
    Wittmann M; Schaaf T; Peters I; Wirz S; Urban BW; Barann M
    Anesth Analg; 2008 Jul; 107(1):107-12. PubMed ID: 18635474
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evaluation of a single-dose, extended-release epidural morphine formulation for pain after knee arthroplasty.
    Hartrick CT; Martin G; Kantor G; Koncelik J; Manvelian G
    J Bone Joint Surg Am; 2006 Feb; 88(2):273-81. PubMed ID: 16452737
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials.
    Grosset AB; Roberts MS; Woodson ME; Shi M; Swanton RE; Reder RF; Buckley BJ
    J Pain Symptom Manage; 2005 Jun; 29(6):584-94. PubMed ID: 15963867
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine.
    Beatty NC; Arendt KW; Niesen AD; Wittwer ED; Jacob AK
    J Clin Anesth; 2013 Aug; 25(5):379-383. PubMed ID: 23965210
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dose equivalence of immediate-release hydromorphone and once-daily osmotic-controlled extended-release hydromorphone: a randomized, double-blind trial incorporating a measure of assay sensitivity.
    Cruciani RA; Katz N; Portenoy RK
    J Pain; 2012 Apr; 13(4):379-89. PubMed ID: 22424912
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Observations on the metabolism of morphine to hydromorphone in pain patients.
    Hughes MM; Atayee RS; Best BM; Pesce AJ
    J Anal Toxicol; 2012 May; 36(4):250-6. PubMed ID: 22511699
    [TBL] [Abstract][Full Text] [Related]  

  • 91. No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.
    Barrington JW; Emerson RH; Lovald ST; Lombardi AV; Berend KR
    Clin Orthop Relat Res; 2017 Jan; 475(1):94-105. PubMed ID: 27339124
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial.
    Mazzocato C; Buclin T; Rapin CH
    Ann Oncol; 1999 Dec; 10(12):1511-4. PubMed ID: 10643545
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial.
    Nalamachu S; Hale M; Khan A
    J Opioid Manag; 2014; 10(5):311-22. PubMed ID: 25350473
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study.
    Park CK; Kang HW; Oh IJ; Kim YC; Kim YK; Na KJ; Ahn SJ; Kim TO; Choi YJ; Song GA; Lee MK
    J Korean Med Sci; 2016 Dec; 31(12):1914-1921. PubMed ID: 27822929
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey.
    Reddy A; Sinclair C; Crawford GB; McPherson ML; Mercadante S; Hui D; Haider A; Arthur J; Tanco K; Dalal S; Dev R; Amaram-Davila J; Adile C; Liu D; Schuler U; Jammi S; Shelal Z; Del Fabbro E; Davis M; Bruera E
    J Palliat Med; 2022 Oct; 25(10):1557-1562. PubMed ID: 35930252
    [No Abstract]   [Full Text] [Related]  

  • 96. Why do emergency providers choose one opioid over another? A prospective cohort analysis.
    O'Connor AB; Rao A
    J Opioid Manag; 2012; 8(6):403-13. PubMed ID: 23264318
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hydromorphone for dyspnoea in terminally ill patients with cancer: case series.
    Sakaguchi T; Kajiyama T
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e836-e838. PubMed ID: 36357345
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Patient-Controlled Subcutaneous Analgesia with Hydromorphone versus Oral Oxycontin for Opioid Titration of Cancer Pain: A Prospective Multicenter Randomized Trial.
    Xiao X; Sun J; Zhang D; Li L; Zhou H; Li Y; Li Q; He Z; Fu Y; Duan Q; Zheng G; Tang Z; Chu Q; Chen Y
    J Pain Res; 2024; 17():1441-1451. PubMed ID: 38628430
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Opioid Switch Dosing in Chronic Cancer Pain: A Prospective Longitudinal Study.
    Wong AK; Klepstad P; Rubio JP; Somogyi AA; Vogrin S; Le B; Philip J
    J Palliat Med; 2024 Mar; 27(3):388-393. PubMed ID: 37955655
    [No Abstract]   [Full Text] [Related]  

  • 100. Clinical Efficacy of Controlled-Release Morphine Tablets Combined with Celecoxib in Pain Management and the Effects on WNK1 Expression.
    Li J; Luan F; Song J; Dong J; Shang M
    Clinics (Sao Paulo); 2021; 76():e1907. PubMed ID: 33503173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.